• English
    • Türkçe
  • English 
    • English
    • Türkçe
  • Login
View Item 
  •   DSpace Home
  • Araştırma Çıktıları / WOS
  • Araştırma Çıktıları / WOS
  • View Item
  •   DSpace Home
  • Araştırma Çıktıları / WOS
  • Araştırma Çıktıları / WOS
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease

Thumbnail
View/Open
Lipoprotein Lipase Gene Polymorphism and Lipid Profile.pdf (147.2Kb)
Date
2004
Author
Duman, Belgin Süsleyici
Türkoğlu, Caner
Akpinar, Belhhan
Güden, Mustafa
Vertii, Alexey
Dak, Esranur
Çağatay, Tülin
Günay, Demet
Buyukdevrim, Ahmet Sevim
Abstract
Context.-Lipoprotein lipase (LPL) plays a central role in lipid metabolism hydrolyzing triglyceride in chylomicrons and very-low-density lipoproteins. The PvuII polymorphic variant of LPL gene is common and might affect risk of coronary artery disease (CAD). Objective.-Our aim was to determine whether LPL-PvuII polymorphism can be considered to be an independent risk factor or a predictor for CAD in Turkish subjects. Design.-We used polymerase chain reaction and restriction enzyme digestion to determine the distribution of the previously described C-->T transition that causes a PvuII polymorphism in intron 6 among healthy blood donors of Turkish origin and among angiographically confirmed CAD patients with comparable ethnic backgrounds. Results.-For the PvuII genotypes within the CAD group (n = 80) the +/- genotype was found in 39 individuals (48.8%) whereas 25 (31.3%) carried the +/+ genotype and 14 (17.5%) carried the -/- genotype. Within the control group (n = 49) the -/- genotype was found in 19 individuals (38.8%) 16 (32.7%) carried the +/- genotype and 14 (28.6%) carried the +/+ genotype. The genotype frequency distribution was significantly different (P = .049) in the CAD and control study groups. The most frequent genotype among CAD patients was +/-
 
this genotype was more frequent in patients than in control subjects. However the -/- genotype was more prevalent in the control group. Lipoprotein lipase-PvuII polymorphism was found to be associated with fasting total cholesterol and low-density lipoprotein cholesterol levels. The +/+ genotype was found to have higher levels of total cholesterol and low-density lipoprotein cholesterol in both the CAD and control groups. Conclusion.-There was a difference in the distribution of LPL-PvuII genotypes between the healthy subjects and the patients with CAD. Lipoprotein lipase-PvuII polymorphisms were not detected as independent risk factors for CAD in this study group but had associations with lipid levels.
 

Source

Archives of Pathology & Laboratory Medicine

Issue

8

Volume

128

Pages

869-874

URI

https://hdl.handle.net/20.500.12469/151
https://www.archivesofpathology.org/doi/full/10.1043/1543-2165(2004)128%3C869:LLGPAL%3E2.0.CO;2

Collections

  • Araştırma Çıktıları / PubMed [194]
  • Araştırma Çıktıları / Scopus [1565]
  • Araştırma Çıktıları / WOS [1518]

Share


DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateBy AuthorsBy TitlesBy SubjectsBy TypesBy LanguagesBy DepartmentsBy PublishersBy KHAS AuthorsBy Access TypesThis CollectionBy Issue DateBy AuthorsBy TitlesBy SubjectsBy TypesBy LanguagesBy DepartmentsBy PublishersBy KHAS AuthorsBy Access Types

My Account

LoginRegister

Statistics

View Google Analytics Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV